eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Documenthome » Draft Guidance for Industry and Staff; Availability: Procedures for Handling Section 522 Postmarket Surveillance Studies

Draft Guidance for Industry and Staff; Availability: Procedures for Handling Section 522 Postmarket Surveillance Studies

Document ID: FDA-2011-D-0514-0001

Comments

Total: 7
Advanced Medical Technology Association - Comment
Posted : 11/16/2011     ID ：FDA-2011-D-0514-0003     Agency : FDA

Nov 14,2011 11:59 PM ET
RTI Biologics, Inc. - Comment
Posted : 12/09/2011     ID ：FDA-2011-D-0514-0004     Agency : FDA

Nov 14,2011 11:59 PM ET
American College of Cardiology - Comment
Posted : 12/09/2011     ID ：FDA-2011-D-0514-0005     Agency : FDA

Nov 14,2011 11:59 PM ET
Johnson & Johnson - Comment
Posted : 12/09/2011     ID ：FDA-2011-D-0514-0006     Agency : FDA

Nov 14,2011 11:59 PM ET
Medical Imaging & Technology Alliance (MITA) - Comment
Posted : 12/09/2011     ID ：FDA-2011-D-0514-0007     Agency : FDA

Nov 14,2011 11:59 PM ET
Cook Group, Inc. - Comment
Posted : 12/09/2011     ID ：FDA-2011-D-0514-0008     Agency : FDA

Nov 14,2011 11:59 PM ET
Biomet, Inc. (Biomet) - Comment
Posted : 12/23/2011     ID ：FDA-2011-D-0514-0011     Agency : FDA

Nov 14,2011 11:59 PM ET